Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Hazards Identification Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity
Home > Albalon-A > Albalon-A(91-75-8)

Albalon-A(91-75-8)

Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Hazards Identification Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity
More
Less

Product Identification

Product Name

Albalon-A

Synonyms

1H-Imidazole-2-methanamine, 4,5-dihydro-N-phenyl-N-(phenylmethyl)-
2-[(N-Benzylanilino)methyl]-2-imidazoline
Allergan A
Antastan
Antistin
Phenazoline

CAS

91-75-8

Formula

C17H19N3

Molecular Weight

265.36

EINECS

202-094-0

RTECS

NJ2000000

RTECS Class

Drug; Primary Irritant

Merck

12,718

Beilstein/Gmelin

233924

Beilstein Reference

5-25-09-00364

More
Less

Physical and Chemical Properties

Appearance

Crystals. Odorless.

Solubility in water

Insoluble

Melting Point

159

Boiling Point

210 - 220 (0.7 torr)

Density

1.188 g/cm3

pKa/pKb

3.72 (pKb)

Usage

Medication.

More
Less

First Aid Measures

Ingestion

Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.

Inhalation

If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.

Skin

Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes.

Eyes

Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.

More
Less

Handling and Storage

Storage

Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.

Handling

All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.

More
Less

Hazards Identification

Inhalation

Pneumonitis, chest tightness, and wheezing have been reported.

Skin

Skin may be flushed, warm and dry after overdose.

Eyes

Anticholinergic effects, such as prolonged dialation of the pupils, nasal dryness and stuffiness, and mouth and throat dryness, can occur with overdose or therapeutic use.

Ingestion

Overdose may cause anticholinergic effects of ileus and diminished bowel sounds. Nausea, vomiting, and loss of appetite may occur .

More
Less

Exposure Controls/Personal Protection

Personal Protection

Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.

Respirators

Use NIOSH/MSHA approved respirator appropriate for exposure of concern.

Exposure Effects

Rapid heart rate is common. Elevated body temperature, abnormally low blood pressure, and elevated blood pressure have been reported. overdose may result in either CNS depression, including coma, or CNS stimulation, such as toxic psychosis. Subsequent seizures are not uncommon, especially in children. A higher incidence of seizures has been reported following pheniramine overdoses. Therapeutic use has been associated with acute dystonic reactions and dyskinesias. In general, there have been few reported teratogenic effects in humans, although animal studies have suggested that certain antihistamines have teratogenic potential. <br>Pyloric stenosis has occurred in infants following maternal use of antihistamines. <br>Small amounts of antihistamines are excreted in breast milk.

More
Less

Fire Fighting Measures

Fire Fighting

Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.

More
Less

Accidental Release Measures

Small spills/leaks

Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.

More
Less

Stability and Reactivity

Stability

No data.

Incompatibilities

Strong oxidizing agents.

More
Less

ContactMore

LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
WebSite
http://www.lgmpharma.com
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
WebSite
http://www.shchemsky.com
HBCChem, Inc.
Tel
+1-510-219-6317
Fax
+1-650-486-1361
WebSite
http://www.warehouse-sample-usa.com
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366
Fax
0755-28363542
WebSite
http://www.chem-strong.com
Wuhan Dahua Pharmaceutical Co., Ltd.
Tel
027-59262863 13277907145 3091977954
Fax
027-59420980
WebSite
http://show.chemicalbook.com/whdhwy01/